Dr Reddy’s Laboratories Ltd. denied plans to implement a 25% workforce value discount by way of an alternate submitting on posted on NSE.
The pharmaceutical producer deemed the information of its plans to cut back workforce prices by 25% through main layoff initiatives, to be “factually incorrect”.
Saying that they “categorically deny” the declare which was first printed in Enterprise Normal’s information article ‘DRL Trims Workforce Prices By 25% Amid Revlimid-Linked Margin Pressure’.
“On this regard, please be aware that the corporate doesn’t touch upon market speculations and there may be at the moment no such occasion or data which requires a disclosure,” the agency mentioned in its alternate submitting.
